These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12378750)

  • 1. Lipid-lowering drugs: French prescribers under pressure.
    Prescrire Int; 2002 Oct; 11(61):158. PubMed ID: 12378750
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention: providing lipid management in a large clinical practice.
    Brown AS
    Manag Care; 2003 Sep; 12(9 Suppl):16-21. PubMed ID: 14535131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical evaluation of the results of lipid regulating treatment in France].
    Ferrières J; Lablanche JM; Pouchain D; Girerd X; Krempf M; Nguyen G; Glanddier PY
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):58-62. PubMed ID: 15724421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked differences in lipid-lowering drug use in Bologna, Italy and Funen, Denmark.
    Bergman U; Anderssen M; Vaccheri A; Larsen J; Montanaro N
    Eur Heart J; 1999 Aug; 20(15):1135. PubMed ID: 10507909
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of physicians' beliefs and practices on cholesterol levels in patients with type 2 diabetes: a longitudinal assessment.
    Franciosi M; Pellegrini F; De Berardis G; Belfiglio M; Di Nardo B; Greenfield S; Kaplan SH; Rossi MC; Sacco M; Tognoni G; Valentini M; Nicolucci A;
    Am Heart J; 2005 Jan; 149(1):104-11. PubMed ID: 15660041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.
    Walley T; Folino-Gallo P; Stephens P; Van Ganse E
    Br J Clin Pharmacol; 2005 Nov; 60(5):543-51. PubMed ID: 16236045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing lipid lowering agents.
    Wheatley G
    Br J Gen Pract; 1995 Jun; 45(395):329. PubMed ID: 7619599
    [No Abstract]   [Full Text] [Related]  

  • 9. GPs as citizens' agents: prescription behavior and altruism.
    Olsen KR; Gyrd-Hansen D; Boegh A; Hansen SH
    Eur J Health Econ; 2009 Oct; 10(4):399-407. PubMed ID: 19083035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid-lowering drugs].
    Fortschr Med Suppl; 1988; 46():13-4. PubMed ID: 2905325
    [No Abstract]   [Full Text] [Related]  

  • 11. Using paper chart based clinical reminders to improve guideline adherence to lipid management.
    Hung CS; Lin JW; Hwang JJ; Tsai RY; Li AT
    J Eval Clin Pract; 2008 Oct; 14(5):861-6. PubMed ID: 19018919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001.
    Joffres MR; Kamath TV; Williams GR; Casey J; Svenson LW
    Can J Cardiol; 2004 Jun; 20(8):767-72. PubMed ID: 15229757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid management in ischemic stroke patients.
    Tan TY; Chang KC; Schminke U; Lin TK; Huang YC; Hung JW; Chen TY
    Clin Neurol Neurosurg; 2007 Nov; 109(9):758-62. PubMed ID: 17693015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in current approaches to lipid lowering.
    Ansell BJ
    Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952
    [No Abstract]   [Full Text] [Related]  

  • 16. [Can we really reach our goals? Arguments for aggressive lipid lowering].
    Internist (Berl); 1999 Sep; 40(9 Suppl Argumente):1-8. PubMed ID: 10528586
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipidemia: treatment with lipid-lowering agents.
    LaRosa JC
    Md Med J; 1988 May; 37(5):401-6. PubMed ID: 3386426
    [No Abstract]   [Full Text] [Related]  

  • 18. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of a cross-sectional survey about lipid-management practices among cardiologists in Pakistan: assessment of adherence to published treatment guidelines.
    Gowani SA; Shoukat S; Taqui AM; Bhulani N; Khalid S; Sheikh A; Halim MS; Samreen S; Jafary FH
    Clin Ther; 2009 Jul; 31(7):1604-14. PubMed ID: 19695410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
    Xie F; Petitti DB; Chen W
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.